9/15/2021The Legislative Approach and System Improvement of China's Compulsory ...

9/13/2021NMPA and MOFCOM Holds Seminar to Boost Drug Regulatory Cooperation am...

9/13/2021NHSA and NHC Issues Joint Notice to Facilitate BMI Drug Negotiation Ou...

9/13/20212021 Internet Hospital Report Unveils Surging Online Healthcare Resour...

9/13/2021Y mAbs/SciClone Granted Priorit Review of BLA for DANELZA (naxitamab-g...

9/13/2021Hutchmed's Amdizalisib Drug Granted Breakthrough Designation by China

9/13/2021ITM and Chengdu Gaotong Isotope Form Chinese JV for Diagnostic and The...

9/10/2021JPO Publicizes Product and Manufacturer Information on the 6th Round o...

9/10/2021Recent Executive Moves

9/9/2021China's Personal Info Protection Law Has Significant Implications for ...

9/8/2021CDE Solicits Public Comments on the Technical Guidance on Clinical Pro...

9/8/2021Sandoz and Bio-Thera Reach China Oncology Biosimilar Deal

9/8/2021Hutchmed, AstraZeneca Launches Orpathys + Tagrisso Combo Trial for Lun...

9/8/2021Frontage Expands Early Drug Discovery Services through the Acquisition...

9/7/2021AffaMed Enters into Strategic Partnership with BJ Tiantan Hospital and...

9/7/2021Sinopharm to Develop Second-Generation mRNA COVID-19 Vaccine

9/7/2021Bayer, BJ Branch of CMA Sign Deal to Boost Innovation

9/7/2021NMPA Announces Package Insert Revision of Diammonium Glycyrrhizinate F...

9/7/2021MSD's KEYTRUDA Approved in China in Combo with Chemotherapy for First-...

9/7/2021GlobalData: China Leads Biosimilar Development and Marketing in APAC

9/7/2021Move over, Shanghai and Beijing? Suzhou wants to be the 'Pharmacy Vall...

9/6/2021NHSA Unveils the Draft Interim Regulations for Medical Insurance Inspe...

9/3/2021NHC Issues the Working Procedures for Adjustment of the List of Drugs ...

9/3/2021JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...

9/3/2021Wyeth Secured Win With Punitive Damages But Courts Had Different Opini...

9/3/2021Investment Prospects in China's Biopharmaceuticals and Biomaterials In...

9/3/2021Healthcare Sector Could Be the Next Target of Chinese Regulatory Crack...

9/1/2021CDE Seeks Comments on Implementation Advice on ICH Guidelines E18, M3(...

9/1/2021Junshi Bio and Coherus Completes Rolling BLA Submission of Toripalimab...

9/1/2021CStone Files Chinese NDA of Sugemalimab for Stage III NSCLC

Page:59/333 Total number of articles:9989: [First][<<] [57] [58] [59] [60] [61] [>>] [End]